Colorectal cancer : pharmacogenetics support for the correct drug prescription
Pharmacogenetics (PGx) in clinical practice is a tool that the clinician can use to guide, in a personalized way, the most suitable treatment that will be administered to the patient. The objective of this review is to summarize in a practical and accessible rational way, the advances that currently exist for the application of PGx in colorectal cancer chemotherapy management through the study of the patients' germline polymorphisms. To define the polymorphisms that can be applied, we rely on three fundamental cornerstones: the recommendations of drug regulatory agencies; the implementation guidelines prepared by expert consortia in PGx and information from clinical annotations (the drug/polymorphism relation) according to the scientific level of evidence assigned by PharmGKB experts.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Pharmacogenomics - 20(2019), 10 vom: 01. Juli, Seite 741-763 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Olivera, Gladys [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antineoplastic Agents |
|---|
| Anmerkungen: |
Date Completed 28.04.2020 Date Revised 28.04.2020 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.2217/pgs-2019-0041 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM299802833 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM299802833 | ||
| 003 | DE-627 | ||
| 005 | 20231225101134.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2217/pgs-2019-0041 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0999.xml |
| 035 | |a (DE-627)NLM299802833 | ||
| 035 | |a (NLM)31368847 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Olivera, Gladys |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Colorectal cancer |b pharmacogenetics support for the correct drug prescription |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.04.2020 | ||
| 500 | |a Date Revised 28.04.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Pharmacogenetics (PGx) in clinical practice is a tool that the clinician can use to guide, in a personalized way, the most suitable treatment that will be administered to the patient. The objective of this review is to summarize in a practical and accessible rational way, the advances that currently exist for the application of PGx in colorectal cancer chemotherapy management through the study of the patients' germline polymorphisms. To define the polymorphisms that can be applied, we rely on three fundamental cornerstones: the recommendations of drug regulatory agencies; the implementation guidelines prepared by expert consortia in PGx and information from clinical annotations (the drug/polymorphism relation) according to the scientific level of evidence assigned by PharmGKB experts | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a clinical implementation | |
| 650 | 4 | |a colorectal cancer | |
| 650 | 4 | |a drug label | |
| 650 | 4 | |a guidelines | |
| 650 | 4 | |a pharmGKB | |
| 650 | 4 | |a pharmacogenetics | |
| 650 | 4 | |a polymorphisms | |
| 650 | 7 | |a Antineoplastic Agents |2 NLM | |
| 700 | 1 | |a Sendra, Luis |e verfasserin |4 aut | |
| 700 | 1 | |a Herrero, María José |e verfasserin |4 aut | |
| 700 | 1 | |a Puig, Carlos |e verfasserin |4 aut | |
| 700 | 1 | |a Aliño, Salvador F |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pharmacogenomics |d 2000 |g 20(2019), 10 vom: 01. Juli, Seite 741-763 |w (DE-627)NLM111671396 |x 1744-8042 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2019 |g number:10 |g day:01 |g month:07 |g pages:741-763 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2217/pgs-2019-0041 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2019 |e 10 |b 01 |c 07 |h 741-763 | ||